FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

KO Haustein

Research Profile

Chemicals & Drugs

Concepts & Ideas

Biological Availability

Procedures

Disorders

Physiology

Biotransformation

Activities & Behaviors

Anatomy

Livers

Co-author Network

Co-Publications
Name

Publications

TOP 3
KO Haustein
[Smoking: health care and politics in flux].
KO Haustein
[Smoking or nicotine as the reason for coronary circulation disorders and possibilities for treatment of nicotine dependence].
W Barthel; G Hüller; KO Haustein
Bioequivalence of allopurinol-containing tablet preparations.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of KO Haustein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1999: KO Haustein
[Smoking: health care and politics in flux].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 1999;93(5):355-61.
1999: KO Haustein
[Smoking or nicotine as the reason for coronary circulation disorders and possibilities for treatment of nicotine dependence].
Deutsche medizinische Wochenschrift (1946) 1999;124(12):363-9.
1999: W Barthel; G Hüller; KO Haustein
Bioequivalence of allopurinol-containing tablet preparations.
International journal of clinical pharmacology and therapeutics 1999;37(3):148-52.
1999: KO Haustein
Smoking tobacco, microcirculatory changes and the role of nicotine.
International journal of clinical pharmacology and therapeutics 1999;37(2):76-85.
1999: KO Haustein
Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon.
Seminars in thrombosis and hemostasis 1999;25(1):5-11.
1999: KO Haustein
[Smoking, cardiovascular diseases and possibilities for treating nicotine dependence].
Wiener medizinische Wochenschrift (1946) 1999;149(1):19-24.
1998: C Böhm; KO Haustein
The effect of pentaerithrityl-tetranitrate on parameters of the microcirculation.
International journal of clinical pharmacology and therapeutics 1998;36(7):398-402.
1997: M Albrecht; KO Haustein
The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
International journal of clinical pharmacology and therapeutics 1997;35(12):580-6.
1997: KO Haustein
State of the art--treatment of peripheral occlusive arterial disease (POAD) with drugs vs. vascular reconstruction or amputation.
International journal of clinical pharmacology and therapeutics 1997;35(7):266-74.
1997: W Barthel; C Böhm; G Hüller; KO Haustein
Bioequivalence of tolbutamide-containing tablet preparations.
International journal of clinical pharmacology and therapeutics 1997;35(1):43-6.
1996: W Barthel; KO Haustein
Cost-benefit analysis--a prerequisite of a rational pharmacotherapy in cardiovascular diseases. Timely thrombolysis in the acute myocardial infarction.
International journal of clinical pharmacology and therapeutics 1996;34(7):277-81.
1995: KO Haustein; U Winkler; A Löffler; G Hüller
Absorption and bioavailability of pentaerithrityl-tetranitrate (PETN, Dilcoran 80).
International journal of clinical pharmacology and therapeutics 1995;33(2):95-102.
1994: KO Haustein; G Thiele; U Stangel
Transport of various substances through human enamel and dentine.
International journal of clinical pharmacology and therapeutics 1994;32(9):483-7.
1994: KO Haustein; R Bauer
Extraordinary efficacy of 16 alpha-gitoxin, an ultra-short acting semi-synthetic digitalis glycoside.
International journal of clinical pharmacology and therapeutics 1994;32(6):299-304.
1994: KO Haustein; G Hüller
Pharmacokinetics of phenprocoumon.
International journal of clinical pharmacology and therapeutics 1994;32(4):192-7.
1993: KO Haustein
Drug-prescription in the five new federal lands--a comparison with the prescription of the old federal lands of Germany.
International journal of clinical pharmacology, therapy, and toxicology 1993;31(8):399-403.
1993: G Hüller; W Barthel; H Klatt; KO Haustein
Determination of N-butyl-scopolamine bromide in human plasma and urine by a HPLC method. Evidence of negligible absorption after oral administration.
Die Pharmazie 1993;48(7):548-9.
1992: KO Haustein; U Winkler; K Dück; F Richard
The reactivity of peripheral vessels of normo- and hypertensives.
International journal of clinical pharmacology, therapy, and toxicology 1992;30(6):214-9.
1991: H Sensing; J Treutler; KO Haustein; G Hüller
[The diagnostic value of the aminophenazone breath test in chronic liver diseases].
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 1991;46(13):478-82.
1991: J Treutler; H Sensing; KO Haustein; G Hüller
[Influence of exogenous factors on the behavior of aminophenazone breath test in chronic liver diseases].
Gastroenterologisches Journal : Organ der Gesellschaft für Gastroenterologie der DDR 1991;51(3-4):132-5.
1991: H Sensing; J Treutler; KO Haustein; G Hüller
[Studies on diagnostic and prognostic validity of aminophenazone breath test in liver cirrhosis].
Gastroenterologisches Journal : Organ der Gesellschaft für Gastroenterologie der DDR 1991;51(3-4):112-6.
1990: KO Haustein; I Assmann; G Hüller
Interaction between nifedipine and cardioactive drugs.
International journal of clinical pharmacology, therapy, and toxicology 1990;28(11):458-61.
1990: KO Haustein
Review: therapeutic concepts of congestive heart failure.
International journal of clinical pharmacology, therapy, and toxicology 1990;28(7):273-81.
1988: J Treutler; H Sensing; KO Haustein; G Hüller
[Behavior of the aminophenazone breath test in chronic liver diseases].
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 1988;43(23):688-92.
1988: KO Haustein; G Hüller
On the pharmacokinetics and metabolism of propiverine in man.
European journal of drug metabolism and pharmacokinetics 1988;13(2):81-90.
1988: G Hüller; KO Haustein; S Scheithauer
Studies on the metabolic pattern of propiverine in urine after single administration.
Die Pharmazie 1988;43(2):91-5.
1988: KO Haustein; M Wesser
Pharmacokinetics of pengitoxin and its therapeutic efficacy in congestive heart failure.
International journal of clinical pharmacology, therapy, and toxicology 1988;26(1):8-15.
1987: KO Haustein; C Hentschel; H Hentschel
The relation of membrane-ATPase activity with congestive heart failure.
International journal of clinical pharmacology, therapy, and toxicology 1987;25(12):651-5.
1987: KO Haustein; H Sensing; M Wesser
Elimination of 16-acetyl-gitoxin in patients suffering from impaired liver function.
International journal of clinical pharmacology, therapy, and toxicology 1987;25(7):379-81.
1987: KO Haustein; H Hentschel
Dose-dependent shortening of systolic time intervals after intake of pengitoxin.
International journal of clinical pharmacology research 1987;7(1):19-25.
1986: B Dietze; KO Haustein; G Hüller; C Brückner
The 14C-aminophenazone breath test in pesticide workers.
International archives of occupational and environmental health 1986;57(3):185-93.
1985: KO Haustein; G Hüller
[Bioavailability of etilefrine from Thomasin and Thomasin sustained-release tablets].
Die Pharmazie 1985;40(11):776-8.
1983: H Sensing; KO Haustein; G Hüller
[Hepatic clearance of aminopyrine in the evaluation of liver function in hormonal contraception].
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 1983;38(23):622-6.
1982: KO Haustein; M Wesser
[Clinico-pharmacological and clinical evaluation of pengitoxin].
Farmakologiia i toksikologiia 1982;45(3):67-8.
1982: KO Haustein; G Hüller; H Sensing
The determination of aminopyrin elimination for control of the metabolic capacity of the liver in man.
European journal of clinical investigation 1982;12(2):157-64.
1981: G Hüller; KO Haustein
[Quantitative thin-layer chromatographic estimation of aminophenazone (I.N.N.), 4-methylaminophenazone and 4-aminophenazone in plasma (author's transl)].
Die Pharmazie 1981;36(8):546-8.
1981: G Hüller; KO Haustein; D Murawski
On the plasma protein binding of 16-acetyl-gitoxin.
International journal of clinical pharmacology, therapy, and toxicology 1981;19(5):200-2.
1980: KO Haustein; I Assmann; H Fiehring
Problems of rapid digitalization in severe congestive heart failure.
European journal of cardiology 1980;11(2):135-46.
1980: KO Haustein; H Hentschel; B Kaiser
Problems of an optimum digitalis therapy.
International journal of clinical pharmacology, therapy, and toxicology 1980;18(8):352-6.